CLINICAL_TRIALS
trial_result
· 2015-02-27
Clinical Trial Update: A Study to Investigate the Influence of MK0859 on Blood Pressure (MK-0859-012)(COMPLETED) [Phase 1]
Summary
A Phase 1 study evaluating MK0859's influence on ambulatory blood pressure has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Ambulatory Blood Pressure | Phase 1 | Status: COMPLETED